ASP

TSX:ASP

Acerus Pharmaceuticals Corporation

  • Stock

CAD

Last Close

0.36

26/01 15:39

Market Cap

2.77M

Beta: 1.03

Volume Today

1.25K

Avg: 1.30K

PE Ratio

−0.09

PFCF: −0.10

    Description

    Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment...Show More

    Earnings

    Earnings per Share (Estimate*)

    -6-5-4-3-2-12016-03-022018-03-202020-03-032021-03-302022-03-30

    Revenue (Estimate*)

    -5M5M10M2016-03-022018-03-202020-03-032021-03-302022-03-30

    *Estimate based on analyst consensus